POLH expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.237800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.373400E-01
Normal-vs-Stage2
4.220600E-01
Normal-vs-Stage3
2.891600E-01
Normal-vs-Stage4
4.661600E-01
Stage1-vs-Stage2
8.965800E-01
Stage1-vs-Stage3
1.721430E-01
Stage1-vs-Stage4
6.220000E-01
Stage2-vs-Stage3
7.815200E-03
Stage2-vs-Stage4
4.870000E-01
Stage3-vs-Stage4
1.713220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.271600E-01
Normal-vs-AfricanAmerican
2.107600E-01
Normal-vs-Asian
3.479800E-01
Caucasian-vs-AfricanAmerican
8.903000E-01
Caucasian-vs-Asian
2.740600E-01
AfricanAmerican-vs-Asian
5.356000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.114400E-01
Normal-vs-Female
4.418000E-01
Male-vs-Female
4.765200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.938400E-01
Normal-vs-Age(41-60Yrs)
4.812000E-01
Normal-vs-Age(61-80Yrs)
4.053600E-01
Normal-vs-Age(81-100Yrs)
3.897400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.283800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.127600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.592800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.269020E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.702600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.050200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.795000E-01
Normal-vs-Daily Drinker
3.069400E-01
Normal-vs-Weekly Drinker
4.263000E-01
Normal-vs-Occasional Drinker
2.079800E-01
Normal-vs-Social Drinker
5.179000E-01
Non Drinker-vs-Daily Drinker
1.882180E-01
Non Drinker-vs-Weekly Drinker
5.987800E-01
Non Drinker-vs-Occasional Drinker
1.790790E-01
Non Drinker-vs-Social Drinker
1.213780E-01
Daily Drinker-vs-Weekly Drinker
1.015610E-01
Daily Drinker-vs-Occasional Drinker
2.098100E-02
Daily Drinker-vs-Social Drinker
6.856100E-03
Weekly Drinker-vs-Occasional Drinker
5.076000E-01
Weekly Drinker-vs-Social Drinker
3.920800E-01
Occasional Drinker-vs-Social Drinker
9.252600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.031800E-01
Normal-vs-Grade 2
8.367600E-02
Normal-vs-Grade 3
1.012410E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.628830E-01
Grade 1-vs-Grade 3
4.829000E-01
Grade 1-vs-Grade 4
3.031800E-01
Grade 2-vs-Grade 3
4.249200E-01
Grade 2-vs-Grade 4
8.367600E-02
Grade 3-vs-Grade 4
1.012410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.954800E-01
Normal-vs-NonDiabetic
4.068600E-01
Diabetic-vs-NonDiabetic
7.829600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.916000E-01
Normal-vs-NoPancreatitis
4.086400E-01
Pancreatitis-vs-NoPancreatitis
7.672800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.306200E-01
Normal-vs-N1
4.229600E-01
N0-vs-N1
8.973000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.922600E-01
Normal-vs-TP53-NonMutant
5.276000E-01
TP53-Mutant-vs-TP53-NonMutant
3.929600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
